DGAP-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Personnel Leadership Change in the Executive Board of Carl Zeiss Meditec AG 30-Sep-2021 / 16:20 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

----------------------------------------------------------------------------------------------------------------------- 


Leadership Change in the Executive Board of Carl Zeiss Meditec AG 
Jena, September 30, 2021 
The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has agreed on a change in the Executive Board of 
the company. Dr. Ludwin Monz, who has been Chief Executive Officer of the company since 2010, will turn over his 
position to Dr. Markus Weber, currently member of the Executive Board of Carl Zeiss AG, on December 31, 2021. The 
transition is happening on the best of terms and at Dr. Monz' own request. 
Dr. Weber has more than 20 years of experience in various management and research and development functions within the 
ZEISS Group and, on the Executive Board of Carl Zeiss AG, is currently responsible for the Semiconductor Technology 
segment. Along with his new role as Chief Executive Officer of Carl Zeiss Meditec AG, Dr. Weber will remain on the 
board of Carl Zeiss AG, assuming the responsibilities of Dr. Monz on that board, who will leave the Executive Board of 
Carl Zeiss AG on December 31, 2021. 
In the view of the Supervisory Board of Carl Zeiss Meditec AG, management continuity is assured via the internal 
succession. The other two members of the Executive Board, Justus Felix Wehmer and Jan Willem de Cler, will remain in 
their current positions.

Contact for investors and press Sebastian Frericks Head of Investor Relations Carl Zeiss Meditec AG Tel.: +49 3641 220-116 E-Mail: investors.meditec@zeiss.com

-----------------------------------------------------------------------------------------------------------------------

30-Sep-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

----------------------------------------------------------------------------------------------------------------------- 


Language:     English 
Company:      Carl Zeiss Meditec AG 
              Göschwitzer Str. 51-52 
              07745 Jena, Germany 
              Germany 
Phone:        +49 (0)3641 220-0 
Fax:          +49 (0)3641 220-112 
E-mail:       investors.meditec@zeiss.com 
Internet:     www.zeiss.de/meditec-ag/ir 
ISIN:         DE0005313704 
WKN:          531370 
Indices:      MDAX, TecDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange 
EQS News ID:  1237251 
 
End of Announcement  DGAP News Service 
=------------

1237251 30-Sep-2021 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1237251&application_name=news

(END) Dow Jones Newswires

September 30, 2021 10:21 ET (14:21 GMT)